Axiom Investment Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72.7K Buy
859
+259
+43% +$20.9K 0.05% 187
2026
Q1
$42.4K Buy
+600
New +$44.9K 0.03% 216
2022
Q4
– Sell
-100
Closed -$6K – 278
2022
Q3
$6K Buy
+100
New +$6.39K 0.01% 284
2019
Q3
– Sell
-27,182
Closed -$1.34M – 345
2019
Q2
$1.34M Buy
27,182
+1,192
+5% +$56K 0.24% 102
2019
Q1
$1.11M Sell
25,990
-9,459
-27% -$418K 0.21% 111
2018
Q4
$1.46M Buy
+35,449
New +$1.52M 0.31% 78

Other funds holding MET

Axiom Investment Management's MET Position: Q2 2026 in Review

Axiom Investment Management increased its MetLife (MET) stake by 43% in Q2 2026, buying an estimated $20.9K and bringing the position to 859 shares worth $72.7K. The position accounts for 0.05% of the portfolio, ranked #187.

Axiom Investment Management first reported a position in MET in Q4 2018 and has held it in 6 quarters since. The position peaked at $1.46M in Q4 2018. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Axiom Investment Management held 859 shares of MetLife worth $72.7K as of Q2 2026.
  • Axiom Investment Management bought 259 MetLife shares in Q2 2026, an estimated $20.9K.
  • MetLife made up 0.05% of Axiom Investment Management's portfolio in Q2 2026, its #187 holding.
  • Axiom Investment Management first reported a position in MetLife in Q4 2018 and has held it in 6 quarters since.
  • Axiom Investment Management's MetLife position peaked at $1.46M in Q4 2018.
  • 1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.